The Goldman Sachs Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat ...
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...
GE HealthCare Technologies Inc. GEHC has recently unveiled the Genesis portfolio, a portfolio of cloud enterprise imaging ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...
Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...